ARKG
- ARK Genomic Revolution ETFInformación clave
| Fecha más antigua | 2014-10-31 |
Información del ETF
| Proveedor del fondo | ARK Invest |
| Índice | Active (No Index) |
| Ratio de gastos | 0.75% |
| Número de posiciones | 42 |
| Fecha de lanzamiento | 2014-10-31 |
| Clase de activo | Equity |
| Cotización | US-listed |
| Sector | Healthcare |
| Estilo de inversión | Growth |
| Sin apalancamiento | Non-leveraged |
Acerca de ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.